Top Story

Rhopressa shows positive topline efficacy results in Rocket 4 phase 3 trial

October 27, 2016

The Rocket 4 phase 3 trial of the once-daily eye drop Rhopressa has shown positive topline 90-day efficacy results in lowering IOP in patients with glaucoma or ocular hypertension, Aerie announced in a press release.

In the Rocket 4 study, which included approximately 700 patients, Rhopressa (netarsudil ophthalmic solution 0.02%) demonstrated non-inferiority compared to twice-daily timolol in patients with baselines above 20 mmHg to below 25 mmHg, according to the release.

In the Journals

Analysis confirms responsiveness of NEI VFQ-25 to changes in BCVA in RIDE, RISE studies

October 27, 2016
Researchers analyzing data from the RIDE and RISE studies confirmed the responsiveness of the National Eye Institute Visual Function Questionnaire-25 in patients with…
Meeting NewsVideo

VIDEO: Laser a viable option for reducing medication burden in glaucoma treatment

October 27, 2016
CHICAGO — At the American Academy of Ophthalmology meeting here, Nathan Radcliffe, MD, discusses the advantages of using laser treatment in glaucoma.
In the Journals

More than 25% of internal medicine residents say patient responsibility ends at discharge

October 27, 2016
Internal medicine residents are uncertain about the duration of their responsibilities for patients who have been discharged, according to survey results published in…

BLOG: Secrets of successful refractive cataract surgery practices, part 2

October 27, 2016
In the first part of this blog we focused on the first five secrets to success with refractive cataract surgery.
More News Headlines »
Original Article

Continuous Curvilinear Capsulorhexis Performed With the VERUS Ophthalmic Caliper

Journal of Refractive Surgery, October 2016, Volume 32 Issue 10
To compare size, circularity, and centration outcomes of continuous curvilinear capsulorhexis (CCC) performed with or…
More »

Current Insights: Applying New Data to Optimize Treatment of Diabetic Retinal Disease

This activity is supported by an educational grant from Bausch + Lomb.

Glaucoma is currently the second leading cause of blindness throughout the world. The goal of glaucoma treatment is to…
More »
Surgical Maneuvers

Managing small pupils during phaco cataract surgery, part 1

October 26, 2016
More »